United Kingdom Intrauterine Contraceptive Devices Market Insight
The United Kingdom Intrauterine Contraceptive Devices Market is growing at an 3.5%CAGR, driven by LARC demand, NHS support, awareness, and improved IUD technologies.
United Kingdom Intrauterine Contraceptive Devices Market Insights Forecasts to 2035
- The United KingdomIntrauterine Contraceptive Devices Market Size Was Estimated at USD 156.3Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 3.5% from 2025 to 2035
- The United Kingdom Intrauterine Contraceptive Devices Market Size is Expected to Reach USD 220.4Million by 2035
Notable Insights for United Kingdom Intrauterine Contraceptive Devices Market
- By product type, hormonal IUDs dominate the UK market with an estimated 55–65% share, driven by high efficacy (>99%) and reduced menstrual bleeding benefits, alongside strong NHS adoption
- Copper IUDs account for around 35–45% share, offering >99% contraceptive effectiveness and preferred non-hormonal option with 5–10 years of protection
- Around 20–30% of UK women using contraception prefer long-acting reversible contraceptives (LARCs), including IUDs, reflecting rising awareness and acceptance supported by NHS family planning programs.
- Over 60–70% of IUD users prefer long-term devices over daily contraceptive methods, with adherence rates above 90% due to convenience, reliability, and low maintenance requirements.
Download the eBook (ToC)
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom Intrauterine Contraceptive Devices Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United Kingdom Intrauterine Contraceptive Devices Market
- Bayer
- CooperSurgical
- Allergan (AbbVie)
- Pfizer
- Viatris
- Eurogine
- HRA Pharma
- Medisafe Distribution
- Others
Recent Developments:
- In June 2024, Barinthus Biotherapeutics reported Phase 2 data for VTP-300 showing reduced HBsAg levels and potential nucleos(t)ide analogue discontinuation in selected chronic hepatitis B patients supporting therapeutic vaccine development.
- In March 2024, Gilead expanded Vemlidy (tenofovir alafenamide) indication for pediatric chronic hepatitis B patients, reinforcing antiviral treatment continuity and supporting long-term hepatitis B management strategies across global markets globally.
Market Segmentation:
United Kingdom Intrauterine Contraceptive Devices Market, By Product Type
- Hormonal IUDs
- Copper IUDs
- Others
United Kingdom Intrauterine Contraceptive Devices Market, By End User
- Hospitals & Clinics
- Gynecology Centers
- Community Healthcare Facilities
- Others
United Kingdom Intrauterine Contraceptive Devices Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Channels
Expert Views:
The UK Intrauterine Contraceptive Devices Market is expected to grow steadily due to increasing preference for long-acting reversible contraception and strong NHS family planning initiatives. Experts highlight that hormonal IUDs will continue to dominate due to high efficacy and non-contraceptive benefits such as menstrual regulation. Growing awareness among women, improved access to insertion services, and advancements in low-dose hormone systems are expected to further drive market expansion through 2035.